Search results
Yi Gang
Author
Mark E Davis
Job title: Director
Author
Marjan Jahangiri
Author
Author(s):
Marianna Fontana
Added:
1 year ago
AHA Conference 2024 - Safety and efficacy outcomes of nexiguran ziclumeran (NTLA-2001) in patients with transthyretin amyloidosis with cardiomyopathy (ATTR-CM).Dr Marianna Fontana (University College London, London, UK) joins us onsite at AHA Conference to discuss the findings from the nexiguran ziclumeran for ATTR-CM trial (NCT04601051).Dr Fontana discusses a phase 1, ongoing, open-label, single…
View more
Added:
7 months ago
Source:
Radcliffe Cardiology
New findings from a large, international registry suggest that in patients with the dual pathology of aortic stenosis and transthyretin-associated cardiac amyloidosis, a combination of aortic valve replacement and disease-specific medication offers the most significant survival benefit.¹ The study (NCT06129331) aimed to clarify the prognostic impact of these treatments in this increasingly…
View more
Lee Fong Ling
Author
The Role of GLP-1 in Heart Failure
Author(s):
Amina Rakisheva
,
Anton Zatsarinnyy
Added:
5 months ago
Editorial
Soledad García Hernández
Research Area(s) / Expertise:
Author
Gábor Széplaki
Job title: Electrophysiologist
Author
David Thompson
Research Area(s) / Expertise:
Job title: Professor of Nursing
Author